A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention.
- DOI
- 10.1016/j.ijpharm.2026.127024
- Published
- 2026 Jul 10
- Container
- International journal of pharmaceutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijpharm.2026.127024,
title = {A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention.},
author = {Sun X and Sharifiaghdam M and Sarrami N and Popescu I and Wretham N and Santos ND and Sutherland B and Leung AWY and Redelmeier T and Abram M and Bally M},
year = {2026},
journal = {International journal of pharmaceutics},
doi = {10.1016/j.ijpharm.2026.127024},
url = {https://doi.org/10.1016/j.ijpharm.2026.127024}
}RIS
TY - JOUR TI - A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention. AU - Sun X AU - Sharifiaghdam M AU - Sarrami N AU - Popescu I AU - Wretham N AU - Santos ND AU - Sutherland B AU - Leung AWY AU - Redelmeier T AU - Abram M AU - Bally M PY - 2026 JO - International journal of pharmaceutics DO - 10.1016/j.ijpharm.2026.127024 UR - https://doi.org/10.1016/j.ijpharm.2026.127024 ER -
APA
X, S., M, S., N, S., I, P., N, W., ND, S., B, S., AWY, L., T, R., M, A., & M, B. (2026). A novel liposomal formulation of irinotecan comprising a combination of copper complexation and a transmembrane pH gradient to significantly improve irinotecan encapsulation and retention.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127024
Source records
- pubmed · retrieved 2026-09-27T06:27:05.454Z